Contraception

Contraception · ISSN (e) 1879-0518 · 135 papers in corpus
other 1996
doi:10.1016/s0010-7824(96)00193-x ·PMID:8922876

Relatively low doses of the antiprogestin mifepristone (RU 486) have recently proven to be efficient for a variety of possible clinical uses of the drug. However, the pharmacokinetics after low single oral doses have not been characterized.…

observational 1994
doi:10.1016/0010-7824(94)90108-2 ·PMID:8137625

The relation between contraceptive methods and risk of pelvic endometriosis has been analyzed in a case-control study. Cases were 376 women with laparoscopically or laparotomically confirmed pelvic endometriosis admitted to a network of Obs…

rct 1994
doi:10.1016/0010-7824(94)90042-6 ·PMID:8200218

The present study was designed to examine the effect RU 486 administration on steroid hormone levels in serum and decidua. Sixty women at 6-7 weeks gestation were divided into three groups. The first group took a placebo 24 hours before int…

observational 1992
doi:10.1016/0010-7824(92)90142-g ·PMID:1591923

Prostaglandin levels in plasma and peritoneal fluid were determined in 10 sterilized women with pelvic pain without pathological findings. Another 15 healthy women were regarded as controls. The 6-keto-PGF1 alpha levels in peritoneal fluid …

observational 1992
doi:10.1016/0010-7824(92)90108-6 ·PMID:1617966

Serum and endometrial sodium (Na) and potassium (K) levels and serum estradiol, progesterone, testosterone and cortisol were measured in the mid-follicular and mid-luteal phases of the menstrual cycle in 20 Lippes loop and 20 CuT-200 IUCD u…

rct 1991
doi:10.1016/0010-7824(91)90149-a ·PMID:1797462

A levonorgestrel-releasing IUD and the Copper T 380Ag IUD were in randomized comparison for seven years in five clinics. In two other clinics the randomized study was truncated at five years, but use of the Copper T continued. No pregnancie…

other 1991
doi:10.1016/0010-7824(91)90077-s ·PMID:1649733

Arachidonic acid metabolites produced by primary cultures of human endometrial cells derived from biopsies obtained before and after exposure to 20 micrograms/day levonorgestrel for 84 +/- 1 days were analysed by reverse phase HPLC. This re…

observational 1990
doi:10.1016/0010-7824(90)90057-3 ·PMID:2347195

In order to determine associations between pelvic inflammatory disease (PID) and contraceptive, sexual, and social life events, 620 Danish women aged 15-54 were invited to participate in an in-depth interview. Of 585 participating women, 45…

review 1989
doi:10.1016/0010-7824(89)90123-6 ·PMID:2656085

Information from published studies testing the effect of hormonal and mechanical interceptive methods in post-coital contraception was pooled with the aim of assessing the efficacy of various regimens. The pooled failure rates were 0.6% (19…

observational 1988
doi:10.1016/0010-7824(88)90157-6 ·PMID:3197418

Mid-luteal phase total urinary oestrogen excretion was found to be significantly reduced in women who had previously undergone tubal sterilization at least two years before assay; pregnanediol levels at or below 2.0 mg/24 hrs were significa…

review 1987
doi:10.1016/0010-7824(87)90120-x ·PMID:2824126
nonrandomized-trial 1987
doi:10.1016/0010-7824(87)90099-0 ·PMID:3677676

Fifty-three volunteer women using Copper T 220C IUDs, complaining of increased menstrual bleeding, received per os 1 g, three times a day, of acetylsalicylic acid, for 5 days, during their menstrual periods. Menstrual bleeding for each pati…

review 1987
doi:10.1016/0010-7824(87)90059-x ·PMID:3311624

This review addresses itself to summarizing the more recent studies published on the bioconversion of arachidonic acid in the human endo- and myometrium during the normal menstrual cycle and in women with increased menstrual blood loss. The…

rct 1986
doi:10.1016/0010-7824(86)90042-9 ·PMID:3533419

Twenty-seven women requesting postcoital contraception were randomly allocated to take an ethinylestradiol/dl-norgestrel combination or danazol. Urine specimens were assayed for luteinising hormone (LH) and pregnanediol-3-glucuronide (P3G) …

lab-animal 1986
doi:10.1016/0010-7824(86)90094-6 ·PMID:3780239

Administration of a combination formulation of danazol (100 mg/day; oral) plus testosterone enanthate (TE) (50 mg/15 days; i.m.) for 30 to 60 days in adult male langur monkeys resulted in the reversible suppression of testicular function wi…

lab-animal 1985
doi:10.1016/0010-7824(85)90008-3 ·PMID:4006468

Changes in the biochemical composition of semen, which reflect the accessory sex organ functions, following danazol (100 mg/day; orally) plus testosterone enanthate (50 mg/month; i.m.) administration have been investigated in langur monkey.…

nonrandomized-trial 1985
doi:10.1016/0010-7824(85)90016-2 ·PMID:3936678

Pharmacokinetic and pharmacodynamic effects of a vaginal ring releasing 20 micrograms/day levonorgestrel (L-NOG) have been studied in 15 women. Serum levels of L-NOG, estradiol and progesterone were measured three times a week in a control …

rct 1984
doi:10.1016/0010-7824(84)90080-5 ·PMID:6236952

Eight healthy (apart from pelvic endometriosis) women were given daily doses of 0.125, 0.250 and 0.500 mg of desogestrel or 5 mg of lynestrenol orally in a randomized order. Duration of each treatment was 6 weeks. Serum was analyzed for sex…

lab-animal 1983
doi:10.1016/s0010-7824(83)80009-2 ·PMID:6627947

The effects of danazol on luteinizing hormone (LH) release by estradiol (E2) were examined in a sequential double chamber superfusion system by superfusing the mediobasal hypothalamus (MBH) and pituitary excised from normal female rats in d…

rct 1983
doi:10.1016/0010-7824(83)90054-9 ·PMID:6839757

A postcoital contraceptive with a lower incidence of nausea and vomiting than oestrogen-progestogen combinations would be a significant advance. During a nine-month period, 101 women were treated at the Margaret Pyke Centre in London with e…

lab-animal 1983
doi:10.1016/0010-7824(83)90069-0 ·PMID:6641226

Danazol in combination with testosterone enanthate was administered to adult male rabbits to assess the structural and functional activity of epididymis. Seminal, biochemical and histological studies were made throughout the experiment. Spe…

nonrandomized-trial 1982
doi:10.1016/0010-7824(82)90132-9 ·PMID:6820337

The pharmacokinetic and pharmacodynamic effects of vaginal devices releasing levonorgestrel (L-NOG) at a constant rate (in vitro release: approximately 20 micrograms/day) were studied in a group of 20 normally menstruating women during a pe…

other 1982
doi:10.1016/0010-7824(82)90026-9 ·PMID:7075188

Because they seemed to be an overlooked, underutilized, and underdeveloped means of contraception, cervical caps were offered to patients in a private gynecological practice and the first 413 acceptors were sent a detailed questionnaire abo…

nonrandomized-trial 1982
doi:10.1016/0010-7824(82)90048-8 ·PMID:7075195

Ethinylestradiol (EE) was given vaginally to circumvent the intestinal metabolism and initial liver passage which follow oral intake. This route of administration was chosen in an effort to enhance the antiovulatory potency of EE, while dec…

other 1981
doi:10.1016/0010-7824(81)90092-5 ·PMID:7297070

The influence of copper ions on myometrial activity was tested in nonpregnant rabbits in vitro and in vivo, and nonpregnant women in vivo. In an organ bath, CuCl2 in concentrations of 3 micro M and higher caused a dose-dependent increase in…